Table 2.

Normalized Ratio of APCR Measured by Different Assays

Assay Patient’s Samples*Homozygous FV Q506 Individual Normal Samples
(1993) (1995) (1998)
Chromogenix-Coatest  
 No dilution  0.50  ND  0.52  0.50  >0.72  
 1:5 dilution in Vdp  ND  0.56  0.80  0.44  >0.70 
 1:10 dilution in Vdp  0.82  0.77  ND  ND  >0.72 
Gradipore-PCl  
 No dilution  ND  ND  0.52  0.43 >0.73  
 1:5 dilution in Vdp  ND  0.50  0.75  0.45 >0.80  
Gradipore-FV Leiden  
 No dilution  ND  ND 0.34  0.26  ND  
 1:5 dilution in Vdp  ND  ND 0.79  0.33  ND  
 1:10 dilution in Vdp  ND  ND 0.84  0.33  ND  
Behring-ProC Global  
 No dilution ND  0.50  0.41  0.38  ND  
 1:5 dilution in Vdp ND  ND  0.81  0.44  ND  
 1:10 dilution in Vdp ND  ND  0.87  0.50  ND 
Assay Patient’s Samples*Homozygous FV Q506 Individual Normal Samples
(1993) (1995) (1998)
Chromogenix-Coatest  
 No dilution  0.50  ND  0.52  0.50  >0.72  
 1:5 dilution in Vdp  ND  0.56  0.80  0.44  >0.70 
 1:10 dilution in Vdp  0.82  0.77  ND  ND  >0.72 
Gradipore-PCl  
 No dilution  ND  ND  0.52  0.43 >0.73  
 1:5 dilution in Vdp  ND  0.50  0.75  0.45 >0.80  
Gradipore-FV Leiden  
 No dilution  ND  ND 0.34  0.26  ND  
 1:5 dilution in Vdp  ND  ND 0.79  0.33  ND  
 1:10 dilution in Vdp  ND  ND 0.84  0.33  ND  
Behring-ProC Global  
 No dilution ND  0.50  0.41  0.38  ND  
 1:5 dilution in Vdp ND  ND  0.81  0.44  ND  
 1:10 dilution in Vdp ND  ND  0.87  0.50  ND 

Abbreviations: ND, not done; Vdp, Factor V deficient plasma.

*

All samples were taken when patient received enoxaparine. Baseline clotting times (without APC) were within normal range in all assay systems.

or Create an Account

Close Modal
Close Modal